KT
UTHR icon

Kanaly Trust’s United Therapeutics UTHR Stock Holding History

Kanaly Trust’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-24
Closed -$3K – 948
2016
Q1 		$3K Sell
24
-39
-62% -$4.93K ﹤0.01% 733
2015
Q4 		$10K Sell
63
-25
-28% -$3.64K ﹤0.01% 569
2015
Q3 		$12K Buy
88
+2
+2% +$321 ﹤0.01% 524
2015
Q2 		$15K Buy
86
+37
+76% +$6.66K ﹤0.01% 501
2015
Q1 		$8K Buy
49
+7
+17% +$1.07K ﹤0.01% 484
2014
Q4 		$5K Buy
+42
New +$5.41K ﹤0.01% 534
2014
Q2 		– Sell
-10
Closed -$1K – 737
2014
Q1 		$1K Buy
+10
New +$1.02K ﹤0.01% 676

Other funds holding UTHR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Kanaly Trust's UTHR Position: Q2 2016 in Review

Kanaly Trust sold out of United Therapeutics (UTHR) in Q2 2016, closing a stake of 24 shares — an estimated $3K sold.

Kanaly Trust first reported a position in UTHR in Q1 2014 and held it in 7 quarters. The position peaked at $15K in Q2 2015. 384 funds tracked by Wall St. Rank hold UTHR as of Q2 2016.

  • Kanaly Trust reported no remaining United Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Kanaly Trust sold 24 United Therapeutics shares in Q2 2016, an estimated $3K.
  • Kanaly Trust first reported a position in United Therapeutics in Q1 2014 and held it in 7 quarters.
  • Kanaly Trust's United Therapeutics position peaked at $15K in Q2 2015.
  • 384 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2016.

Based on Kanaly Trust's 13F filing for Q2 2016, filed 21 Jul 2016.